Pokorney, S., Garonzik, S., Chertow, G. M., Washam, J. B., Mussina, K., Bansal, N., … Granger, C. B. (2020). Pharmacokinetics of apixaban in patients with end stage renal disease on hemodialysis and atrial fibrillation: results from the RENAL-AF trial. In EUROPEAN HEART JOURNAL (Vol. 41, pp. 3373–3373).

Pokorney, S., S. Garonzik, G. M. Chertow, J. B. Washam, K. Mussina, N. Bansal, C. Gadegbeku, et al. “Pharmacokinetics of apixaban in patients with end stage renal disease on hemodialysis and atrial fibrillation: results from the RENAL-AF trial.” In EUROPEAN HEART JOURNAL, 41:3373–3373, 2020.

Pokorney S, Garonzik S, Chertow GM, Washam JB, Mussina K, Bansal N, et al. Pharmacokinetics of apixaban in patients with end stage renal disease on hemodialysis and atrial fibrillation: results from the RENAL-AF trial. In: EUROPEAN HEART JOURNAL. 2020. p. 3373–3373.

Pokorney, S., et al. “Pharmacokinetics of apixaban in patients with end stage renal disease on hemodialysis and atrial fibrillation: results from the RENAL-AF trial.” EUROPEAN HEART JOURNAL, vol. 41, 2020, pp. 3373–3373.

Pokorney S, Garonzik S, Chertow GM, Washam JB, Mussina K, Bansal N, Gadegbeku C, Garcia D, Lopes RD, Mahaffey KW, Middleton J, Thadhani R, Thomas KL, Winkelmayer W, Granger CB. Pharmacokinetics of apixaban in patients with end stage renal disease on hemodialysis and atrial fibrillation: results from the RENAL-AF trial. EUROPEAN HEART JOURNAL. 2020. p. 3373–3373.